Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
(In millions, except per share data) | ||||||
| ||||||
Business Outlook |
| Three Months Ending December 28, 2019 | ||||
|
| GAAP Measure |
| Non-GAAP Adjustments |
| Non-GAAP Measure |
Gross margin |
| 60.3% |
| 0.2% |
| 60.5% |
|
|
|
|
|
|
|
Operating expenses |
| $113 |
| $23 |
| $90 |
|
|
|
|
|
|
|
Effective tax rate |
| 8.0% |
| 3.5% |
| 11.5% |
|
|
|
|
|
|
|
Diluted earnings per share - low |
| $0.33 |
| $0.51 |
| $0.84 |
|
|
|
|
|
|
|
Diluted earnings per share - high |
| $0.43 |
| $0.51 |
| $0.94 |
Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
| |||
| September 28,
|
| December 29,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 237,056 |
| $ 197,043 |
Short-term investments | 457,879 |
| 416,779 |
Accounts receivable, net | 76,169 |
| 73,194 |
Inventories | 71,453 |
| 74,972 |
Prepaid expenses and other current assets | 52,609 |
| 64,650 |
Total current assets | 895,166 |
| 826,638 |
Property and equipment, net | 136,601 |
| 139,049 |
Goodwill | 397,344 |
| 397,344 |
Other intangible assets, net | 140,941 |
| 170,832 |
Other assets, net | 67,126 |
| 90,491 |
Total assets | $1,637,178 |
| $1,624,354 |
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 38,724 |
| $ 41,171 |
Deferred revenue and returns liability | 21,827 |
| 22,494 |
Other current liabilities | 71,485 |
| 81,180 |
Total current liabilities | 132,036 |
| 144,845 |
Convertible debt | 364,802 |
| 354,771 |
Other non-current liabilities | 56,586 |
| 57,448 |
Total liabilities | 553,424 |
| 557,064 |
Commitments and contingencies |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
Common stock – $0.0001 par value; 250,000 shares authorized; 43,373 and 43,088 shares issued and outstanding at September 28, 2019 and December 29, 2018, respectively | 4 |
| 4 |
Additional paid-in capital | 112,251 |
| 107,517 |
Retained earnings | 970,893 |
| 961,343 |
Accumulated other comprehensive income (loss) | 606 |
| (1,574) |
Total stockholders' equity | 1,083,754 |
| 1,067,290 |
Total liabilities and stockholders' equity | $1,637,178 |
| $1,624,354 |